Waltham, MA - Digoxin use is linked to mortality in patients with end-stage renal disease (ESRD), according to the results of a retrospective cohort study reported online June 24, 2010 in the Journal ...

Digoxin use among patients who are on hemodialysis (HD) may increase their risk of death, especially if they have low predialysis potassium levels, a study showed. HD patients who used digoxin had a ...

Patients with atrial fibrillation (AFib) who are given digoxin to control their symptoms have an increased risk of death, whether or not they have a diagnosis of heart failure, compared with patients ...

Digoxin is associated with a significant increase in deaths in patients with atrial fibrillation (AF), finds study published in European Heart Journal. Digoxin is extracted from the foxglove plant ...

There is conflicting evidence about whether digoxin, a drug that has been used worldwide for centuries to treat heart disease, might contribute to an increase in deaths in patients with atrial ...

We had an older female with chronic kidney disease who started complaining about seeing yellow lights and being short of breath. She had a history of heart failure and was treated with digoxin. When ...

Digoxin is eliminated mainly by the kidney through glomerular filtration and P-glycoprotein (P-gp) mediated tubular secretion. Toddlers and young children require higher doses of digoxin per kilogram ...

Despite more than 200 years of use, digoxin remains controversial in the management of HF. This past year, multiple observational studies came to divergent conclusions regarding the benefit or harm of ...

Gemtesa is used to treat urinary urgency, frequency, and incontinence caused by an overactive bladder in adults. This includes certain males with benign prostatic hyperplasia (BPH). Digoxin (Lanoxin) ...

Digoxin 0.25mg/mL; soln for IV or IM inj. Lanoxin (digoxin) Injection, 500 mcg (0.5 mg) in 2 mL (250 mcg [0.25 mg] per mL); box of 10 ampules or 10 vials. Lanoxin (digoxin) Injection Pediatric, 100 ...

Digoxin 0.1mg/mL; soln for IV or IM inj. Lanoxin Tablets: Store at 25°C (77°F); excursions permitted to 15 to 30°C (59 to 86°F) [See USP Controlled Room Temperature] in a dry place and protect from ...